Anti-connective tissue growth factor (CTGF/CCN2) monoclonal antibody attenuates skin fibrosis in mice models of systemic sclerosis

BACKGROUND: Systemic sclerosis (SSc) is characterized by fibrosis of the skin and internal organs. Although the involvement of connective tissue growth factor (CTGF/CCN2) has been well-documented in SSc fibrosis, the therapeutic potential of targeting CTGF in SSc has not been fully investigated. Our...

Descripción completa

Detalles Bibliográficos
Autores principales: Makino, Katsunari, Makino, Tomoko, Stawski, Lukasz, Lipson, Kenneth E., Leask, Andrew, Trojanowska, Maria
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2017
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5470189/
https://www.ncbi.nlm.nih.gov/pubmed/28610597
http://dx.doi.org/10.1186/s13075-017-1356-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5470189/
https://www.ncbi.nlm.nih.gov/pubmed/28610597
http://dx.doi.org/10.1186/s13075-017-1356-3

Ejemplares similares